Symbiotec Pharmalab Limited (NSE:SYMBIOTEC)
1,566.00
-45.30 (-2.81%)
Last updated: Nov 16, 2026, 3:29 PM IST
| Market Cap | 100.63B |
| Revenue (ttm) | 9.69B +28.9% |
| Net Income | 1.27B +30.7% |
| EPS | 20.63 +18.9% |
| Shares Out | 64.26M |
| PE Ratio | 75.90 |
| Forward PE | 61.23 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 362,537 |
| Open | 1,626.00 |
| Previous Close | 1,611.30 |
| Day's Range | 1,533.00 - 1,663.90 |
| 52-Week Range | 934.20 - 1,664.90 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 1,654.00 (+5.62%) |
| Earnings Date | Nov 5, 2026 |